PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-13

Date Title Company
13-Apr-2026 NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling Businesswire
13-Apr-2026 SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard® Businesswire
13-Apr-2026 Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer Businesswire
13-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
13-Apr-2026 Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors Businesswire
13-Apr-2026 Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu Businesswire
13-Apr-2026 Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026 Businesswire
13-Apr-2026 Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026 Businesswire
13-Apr-2026 Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Businesswire
13-Apr-2026 Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer Businesswire
13-Apr-2026 Lineage Announces Formation of Scientific Advisory Board Businesswire
13-Apr-2026 AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility Businesswire
13-Apr-2026 Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors Businesswire
13-Apr-2026 NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 Businesswire
13-Apr-2026 Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria Businesswire
13-Apr-2026 Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 Businesswire
13-Apr-2026 Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy Businesswire
13-Apr-2026 Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy Businesswire
13-Apr-2026 Leukogene Therapeutics Announces Two Presentations at the AACR Annual Meeting 2026 Highlighting MHC Class II-Engager Immunotherapies Businesswire
13-Apr-2026 From Fitness Bands to Smart Health: Wearable Technology Industry on the Rise! Wissen Research Pvt. Ltd.